IP Verse

Ablynx competitive analysis

Loading summary...

Latest oppositions filed by Ablynx

Explore patent oppositions filed by Ablynx against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3059337
Adaptive Immunity Profiling And Methods For Generation Of Monoclonal AntibodiesADAPTIVE BIOTECHNOLOGIESJan 31, 2020
EP2708558
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 21, 2018
EP2708559
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 21, 2018
EP2835380
Method Of Blocking Vascular Leakage Using An Anti-Ang2 AntibodySAMSUNG ELECTRONICSJun 6, 2018
EP2855678
Methods For Selecting Binders By Phage Display And Masked SelectionCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSMay 23, 2018
EP2552955
Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 2, 2018

Latest patents of Ablynx opposed by its competitors

Explore Ablynx's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3248986
Jan 26, 2022Immunoglobulin Variable Domains1
EP2982690
Jan 27, 2021Method For The Production Of Domain Antibodies1
EP3143042
Jun 10, 2020Improved Immunoglobulin Variable Domains1
EP3049439
Dec 25, 2019Bispecific Nanobodies1
EP2632946
Dec 6, 2017Method For The Production Of Immunoglobulin Single Variable Domains1

Latest publications and patents of Ablynx New

Explore the latest publications and patents granted to Ablynx, showcasing their recent innovations and technological advancements.

Last updated on: Oct 17, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ablynx

EP3248986
Jan 26, 2022Immunoglobulin Variable DomainsGranted And Under Opposition
EP2982690
Jan 27, 2021Method For The Production Of Domain AntibodiesOpposition Rejected
EP3143042
Jun 10, 2020Improved Immunoglobulin Variable DomainsOpposition Rejected
EP3049439
Dec 25, 2019Bispecific NanobodiesOpposition Rejected
EP2513145
Jan 24, 2018Single Variable Domain Antibodies Against Ox40L, Constructs And Therapeutic UseNo Opposition Filed Within Time Limit
EP2747782
Jan 17, 2018Prolonged Inhibition Of Interleukin-6 Mediated SignalingNo Opposition Filed Within Time Limit
EP2152747
Jan 3, 2018Amino Acid Sequences Directed Against Rank-L And Polypeptides Comprising The Same For The Treatment Of Bone Diseases And DisordersNo Opposition Filed Within Time Limit
EP2632946
Dec 6, 2017Method For The Production Of Immunoglobulin Single Variable DomainsOpposition Rejected

Latest PTAB cases involving Ablynx

Discover the latest PTAB cases involving Ablynx, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ablynx with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ABLYNX65 - -
BOXALL IPM1 - - -
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS - 17 - -
CHUGAI SEIYAKU KABUSHIKI KAISHA377 - 1